HLA-C and neoplasm: The negative impact on tumor antigen priming potentially exerted by immunosuppressive drugs could also at least in part explain these findings, in particular considering that CNIs, the most frequently used drugs administered to our cohort of SOT patients, were shown to markedly inhibit antigen presentation through both MHC class I and II (45).